Back to top

L'institut Servier. Supporting research. Fostering vocations

Long COVID risk small in children
Researchers find a high burden of non-specific persistent symptoms in children aged 14 years or younger, with SARS-CoV-2 infection adding to this only slightly.
Adolescent, young adult patients might benefit from intensive rhabdomyosarcoma treatment
Adolescent and young adults with rhabdomyosarcoma have more aggressive disease than their paediatric counterparts and might benefit from intensive treatment strategies, suggests an analysis of two European paediatric Soft tissue sarcoma Study Group (EpSSG) trials.
Genetic testing has variable diagnostic yield in congenital diaphragmatic hernia
Genetic testing can identify an underlying cause in more than half of complex/syndromic infants with congenital diaphragmatic hernia (CDH), but factors underlying isolated cases remain elusive, say researchers.

Pages

Annual Scientific Sessions

2021 EDITION

Heterogeneity in diabetes and beta cells

Neurodegeneration: Mechanisms and therapeutic targets

This year over two days in November, L'Institut Servier organizes Scientific Days in Paris, which includes 2 Scientific Colloquiums on different themes.

Consult the previous colloquia publications
cover video
2021 COLLOQUIUM
November 17th, 2021
HETEROGENEITY IN DIABETES
AND BETA CELLS
Chaired by: Professors Christian BOITARD and Raphaël SCHARFMANN

Learn more
2021 colloquium
November 18th, 2021
Neurodegeneration: Mechanisms and therapeutic targets
Chaired by: Professors Didier Leys and Jean-Louis Mas

Learn more
L'Institut SERVIER is a non-profit association under French law.
Its aim is to promote all forms of scientific and medical knowledge thus contributing to medical progress,
patient wellbeing and physician expectations.

Colloquia
organized

21

Laureate
Symposium

5

Grants
allocated

274

Pasteur-Weizmann-
Servier Prize
award

7